CryoPort (CYRX) Set to Announce Earnings on Thursday

Key Points

• CryoPort is scheduled to report Q3 2026 results after the market closes on November 5. Analysts expect a loss of $0.19 per share on revenue of approximately $48.68 million.
• In the prior quarter, CryoPort reported a $0.20-per-share loss, missing estimates by $0.01, while revenue of $48.97 million exceeded expectations. Analysts project full-year and next-year losses of $0.83 and $0.78 per share, respectively.
• Analyst sentiment remains favorable, with a “Moderate Buy” consensus. Eight analysts rate the stock Buy and two rate it Hold, with an average price target of $19.33; the stock recently traded at $18.64.

CryoPort (NASDAQ:CYRX - Get Free Report) is expected to issue its Q3 2026 results after the market closes on Thursday, November 5th. Analysts expect CryoPort to post earnings of ($0.19) per share and revenue of $48.68 million for the quarter. Investors are encouraged to explore the company's upcoming Q3 2026 earnings overview page for the latest details on the call scheduled for Thursday, November 5, 2026 at 5:00 PM ET.

CryoPort (NASDAQ:CYRX - Get Free Report) last issued its earnings results on Thursday, August 6th. The company reported ($0.20) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.19) by ($0.01). The business had revenue of $48.97 million during the quarter, compared to the consensus estimate of $48.18 million. CryoPort had a negative net margin of 20.05% and a negative return on equity of 7.20%. On average, analysts expect CryoPort to post ($0.83) EPS for the current fiscal year and ($0.78) EPS for the next fiscal year.

CryoPort Stock Up 1.2%

CYRX stock opened at $18.64 on Thursday. CryoPort has a twelve month low of $7.61 and a twelve month high of $18.88. The company has a market cap of $944.12 million, a P/E ratio of -20.71 and a beta of 1.96. The business's fifty day moving average is $16.91 and its 200-day moving average is $13.24.

Insider Activity

In related news, CEO Jerrell Shelton sold 28,800 shares of the stock in a transaction that occurred on Tuesday, August 11th. The stock was sold at an average price of $14.91, for a total transaction of $429,408.00. Following the completion of the sale, the chief executive officer directly owned 1,201,814 shares of the company's stock, valued at approximately $17,919,046.74. This represents a 2.34% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 9.50% of the company's stock.

Analyst Upgrades and Downgrades

Several brokerages have commented on CYRX. BTIG Research upped their target price on shares of CryoPort from $25.00 to $26.00 and gave the company a "buy" rating in a research note on Tuesday, October 13th. Roth Capital reiterated a "buy" rating and issued a $21.00 target price on shares of CryoPort in a report on Friday, August 7th. Robert W. Baird set a $26.00 price target on shares of CryoPort in a research report on Tuesday, October 13th. Weiss Ratings raised shares of CryoPort from a "sell (d)" rating to a "hold (c-)" rating in a report on Thursday, October 8th. Finally, Piper Sandler upgraded shares of CryoPort to a "buy" rating in a research report on Tuesday, October 13th. Eight investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company's stock. According to data from MarketBeat, CryoPort currently has an average rating of "Moderate Buy" and an average target price of $19.33.

CryoPort Company Profile

CryoPort, Inc NASDAQ: CYRX provides temperature-controlled supply chain solutions for the life sciences industry. The company supports the transportation, storage and management of biological materials, including cell and gene therapies, vaccines, biologics, reproductive materials and other temperature-sensitive products.

Its offerings include cryogenic and refrigerated shipping containers, biological material storage, transportation logistics, shipment monitoring and related supply chain management services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.